Monday, 3 February 2014

Two Strategies Lead to Similar Survival in RCC

SAN FRANCISCO (MedPage Today) -- Sequential targeted therapy for metastatic renal cell carcinoma led to similar survival, regardless of which agent was used first, according to the first randomized study of the issue. via MedPageToday.com - medical news plus CME for physicians Read More Here..


Lake forest health and fitness http://ift.tt/1bX7nM1

No comments:

Post a Comment